121b.0909-Should coronary calcium screening be used in CV prevention strategies (Bonow, nejm)-.pdf | 458.52Kb | September 18 2009 |
121c.0909-Relation between FRS and the presence of functionnally relevant coronary lesions ... (Nucifora, AJC)-.pdf | 109.09Kb | September 18 2009 |
122.0910-Prevalence of polyvascular disease in patients referred for PAD (Vidakovic, ejves)-.pdf | 243.60Kb | September 18 2009 |
131.0908-Use of smokeless tobacco and risk of MI and Stroke. SR, MA (Boffetta, bmj)-.pdf | 146.75Kb | September 18 2009 |
133.0909-Glucose control and CVD in T2 diabetes, SR (Kelly, Ann Int Med)-.pdf | 200.96Kb | September 18 2009 |
212.0909-Comparative epidemiology of stroke and acute MI. Dijon vascular projet (Gentil, JNNP)-.pdf | 157.63Kb | September 18 2009 |
231.0909-Noninvasive MRI of cerebral perfusion in patients with carotid artery stenosis (Bokkers, Neurology)-.pdf | 590.51Kb | September 18 2009 |
233.0909-Thrombus size and Doppler embolic signal intensity (Martin, CVD)-.pdf | 407.04Kb | September 18 2009 |
241.0908-Asymp moderate ICA stenosis, MRI-depicted IPH predicts risk of cerebrovascular ischemic events (Singh, Radiology)-.pdf | 302.66Kb | September 18 2009 |
241.0909-Computer assisted analysis of heterogeneity on B-mode imaging predicts instability of asympt. CS (Hashimoto, CVD)-.pdf | 534.67Kb | September 18 2009 |
241.0909-Effects of Atorvastatin on carotid atherosclerotic plaqyues ... (Yamada, CVD)-.pdf | 302.91Kb | September 18 2009 |
251.0909-Atherosclerotic plaque progression in carotid arteries, Monitoring with hsr-MRI (Boussel, Radiology)-.pdf | 410.44Kb | September 18 2009 |
255.0910-CAVATAS, long-term follow-up (Ederle, Lancet Neurol)-.pdf | 142.04Kb | September 18 2009 |
255.0910-CAVATAS, long-term follow-up. Restenosis (Bonati, Lancet Neurol)-.pdf | 144.05Kb | September 18 2009 |
255.0910-Poor outcomes after EVAR Tt of symptomatic carotid stenosis, time for a moratorium (Rothwell, Lancet Neurol)-.pdf | 65.96Kb | September 18 2009 |
274.0909-1 Stroke after carotid surgery and relationship with carotid stenosis (Li, Arch Neurol)-.pdf | 88.29Kb | September 18 2009 |
274.0909-2 Translating what is known about neurological cns after CABPG into action (Caplan, Arch Neurol)-.pdf | 56.00Kb | September 18 2009 |
278.0909-FO perméable et AIC, controverses et incertitudes persistent (Mas, Rev Med Int)-.pdf | 145.34Kb | September 18 2009 |
316.0910-A dynamic objective evaluation of PAD by NIRS (Manfredini, ejves)-.pdf | 502.80Kb | September 18 2009 |
322.0910-Prognostic value of impaired walking distance on long-term outcome in known or suspected PAD patients (Liefde, ejves)-.pdf | 311.41Kb | September 18 2009 |
331.0908-Benefits of low-intensity pain-free treadmill exercice on functional capacity of patients with IC due to PAD (Barak, Angiology)-.pdf | 131.24Kb | September 18 2009 |
331.0908-Significance of close surveillance of patients with PAD (Barrows, Angiology)-.pdf | 119.78Kb | September 18 2009 |
331.0910-Drug therapy for improving walking distance in IC, SR.MA of RCTs (Momsen, ejves)-.pdf | 1.11Mb | September 18 2009 |
331.0910-Predictors of walking distance after supervised exercise therapy in patients with IC (Kruidenier, ejves)-.pdf | 146.92Kb | September 18 2009 |
350.0908-Atherosclerotic RAS, Medical therapy alone or in Combination with revascularization (Karagiannis, Angiology)-.pdf | 122.12Kb | September 18 2009 |
615.0909-A lower recurrent DVT risk in W vs M is explained by sex-specific RF at 1st DVT in thrombophilic families (Lijfering, Blood)-.pdf | 221.90Kb | September 18 2009 |
615.0909-Immobilization and the risk of VTE. Epidemiological studies MA (Pottier, TR)-.pdf | 545.65Kb | September 18 2009 |
620.0910-Risk stratification for VTE in hospitalized patients in a developing country, prospective study (Awidi, JTT)-.pdf | 205.18Kb | September 18 2009 |
623.0909-VTE disesae in pregnancy (Martineau, PGMJ)-.pdf | 409.47Kb | September 18 2009 |
645.0909-Catheter-directed thrombolysis for Tt of UE-DVT (Vik, CVIR)-.pdf | 188.74Kb | September 18 2009 |